| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 12/23/2009 | WO2009154565A1 Combination therapies against cancer |
| 12/23/2009 | WO2009154454A1 Regulation of the expression of a protein in a mammalian cell |
| 12/23/2009 | WO2009154452A1 Parvoviral capsid with incorporated Gly-Ala repeat region |
| 12/23/2009 | WO2009154400A2 Method for producing sterility-derived genetically modified grasses |
| 12/23/2009 | WO2009154357A2 Human papilloma virus detection method and detection kit |
| 12/23/2009 | WO2009154334A1 Iborange gene involved in carotenoid accumulation from ipomoea batatas |
| 12/23/2009 | WO2009154320A1 Aureobasidium pullulans np-1221 kctc 11265bp and a producing method for exo-type beta-glucan using the same |
| 12/23/2009 | WO2009154259A1 Primer for analysis of androgen receptor gene |
| 12/23/2009 | WO2009154247A1 Thermostable 1,5-anhydroglucitol dehydrogenase, and method for measurement of 1,5-anhydroglucitol by using the same |
| 12/23/2009 | WO2009154122A1 Coryneform bacterium transformant having improved d-xylose-utilizing function |
| 12/23/2009 | WO2009154046A1 Surface-roughened high-density functional particle, method for producing the same, and method for processing target substance using the same |
| 12/23/2009 | WO2009154025A1 ANTIBODY AGAINST OXIDIZED LDL/β2GPI COMPLEX AND USE OF THE SAME |
| 12/23/2009 | WO2009154016A1 Method of evaluating pathogenicity of pathogenic bacterium, kit for evaluating pathogenicity and gene for evaluating pathogenicity |
| 12/23/2009 | WO2009153992A1 Cdca1 epitope peptides and vaccines containing the same |
| 12/23/2009 | WO2009153960A1 Glycosylated glp-1 peptide |
| 12/23/2009 | WO2009153563A1 Virus purification |
| 12/23/2009 | WO2009153518A2 Novel fusion proteins and use thereof for preparing hepatitis c vaccines |
| 12/23/2009 | WO2009153418A1 Harp peptides inhibiting tumour growth |
| 12/23/2009 | WO2009153414A1 Modified beta-lactoglobulins for immunotherapy of milk allergy |
| 12/23/2009 | WO2009153302A2 Rna antagonists targeting hsp70-2 |
| 12/23/2009 | WO2009153299A1 Method for filtering nucleic acids, in particular from fixed tissue |
| 12/23/2009 | WO2009153294A1 Use of a tpb salt for the separation of biomolecules |
| 12/23/2009 | WO2009153208A1 Plants having enhanced yield-related traits and a method for making the same |
| 12/23/2009 | WO2009153029A1 Anti-prion protein antibody fragment |
| 12/23/2009 | WO2009152969A1 Recombinant modified vaccinia virus measles vaccine |
| 12/23/2009 | WO2009152944A1 Modified erythropoietin (epo)polypeptides that exhibit increased protease resistance and pharmaceutical compositions thereof |
| 12/23/2009 | WO2009152610A1 Interleukin-2/soluble tgf-beta type ii receptor b conjugates and methods and uses thereof |
| 12/23/2009 | WO2009135212A3 Selective 5' ligation tagging of rna |
| 12/23/2009 | WO2009135056A3 Recombinant dna vectors for expression of human prolactin antagonists |
| 12/23/2009 | WO2009135048A3 Highly pure plasmid dna preparations and processes for preparing the same |
| 12/23/2009 | WO2009131604A3 Attenuated recombinant alphaviruses incapable of replicating in mosquitoes and uses thereof |
| 12/23/2009 | WO2009131423A3 Novel hepatitis a virus antigen gene and transformed plants with the gene |
| 12/23/2009 | WO2009129424A3 Longevity-promoting effects of acetic acid and reishi polysaccharide |
| 12/23/2009 | WO2009122443A3 A tumor model system useful to study multistage cancer |
| 12/23/2009 | WO2009120396A3 Compositions and methods for regulating erythropoientin expression and ameliorating anemia and stimulating erythropoiesis |
| 12/23/2009 | WO2009117346A3 System and method for determining the health of a subject using polymorphic risk markers |
| 12/23/2009 | WO2009117327A3 Compositions and methods for analysis of nucleic acid molecules during amplification reactions |
| 12/23/2009 | WO2009114673A3 Methods for production of atrial progenitors and their differentiation into smooth muscle cells and cardiomyocytes |
| 12/23/2009 | WO2009111704A3 Fig4 gene mutations in neurodegeneration |
| 12/23/2009 | WO2009108693A3 Composition and methods for rapid detection of hiv by loop- mediated isothermal amplification (lamp) |
| 12/23/2009 | WO2009102427A3 Modified rnai polynucleotides and uses thereof |
| 12/23/2009 | WO2009093200A9 Production of progenitor cereal cells |
| 12/23/2009 | WO2009083958A3 Isolated polypeptides, polynucleotides useful for modifying water user efficiency, fertilizer use efficiency, biotic/abiotic stress tolerance, yield and biomass in plants |
| 12/23/2009 | WO2009082525A3 Differentially fluorescent yeast biosensors for the detection and biodegradation of chemical agents |
| 12/23/2009 | WO2009073478A9 Tle3 as a marker for chemotherapy |
| 12/23/2009 | WO2009071681A3 Rna antagonist compounds for the modulation of bcl-2 |
| 12/23/2009 | WO2009019612A3 Lentiviral gene transfer vectors and their medicinal applications |
| 12/23/2009 | WO2001000790A9 Production of the lipidated form of the peptidoglycan-associated lipoproteins of gram-negative bacteria |
| 12/23/2009 | WO2000015247A8 Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists |
| 12/23/2009 | EP2135960A1 Genetic analysis for stratification of cancer risk by determining the allelic profile of the VDR-ApaI and CYP11B2 genes |
| 12/23/2009 | EP2135958A1 Method for evaluation of tissue preservation solution |
| 12/23/2009 | EP2135956A1 Sphingolipid having endoplasmic reticulum localization signal attached thereto, and method for production of ceramide in transformed cell using 4-desaturase |
| 12/23/2009 | EP2135955A1 Biosynthesis of polyketide synthase substrates |
| 12/23/2009 | EP2135953A1 Novel hemopoietin receptor protein, Nr. 10 |
| 12/23/2009 | EP2135952A2 Cripto antagonism of activin and TGF-beta signaling |
| 12/23/2009 | EP2135951A1 Transgenic rodents having ngf beta gene mutants and its preparation methods, the preparation methods of the corresponding mutant proteins and the resulting mutant proteins |
| 12/23/2009 | EP2135950A2 Short interfering ribonucleic acid (siRNA) for oral administration |
| 12/23/2009 | EP2135949A1 MCP-1 binding nucleic acids |
| 12/23/2009 | EP2135948A2 ENA nucleic acid drugs modifying splicing in mRNA precursor |
| 12/23/2009 | EP2135947A1 Antagonists of bacterial sequences |
| 12/23/2009 | EP2135946A1 Method for production of polypeptide |
| 12/23/2009 | EP2135945A1 Method for of transcription-degradation dual regulation for protein by antibiotic |
| 12/23/2009 | EP2135944A1 Endoglucanase ppce and cellulase preparation containing the same |
| 12/23/2009 | EP2135880A1 Anti-prion protein antibody fragment |
| 12/23/2009 | EP2135879A2 Ligand |
| 12/23/2009 | EP2135623A1 Method of treatment of a BCL-2 disorder using BCL-2 antisense oligomers |
| 12/23/2009 | EP2135504A1 Non-transgenic herbicide resistant plants |
| 12/23/2009 | EP2135503A1 METHOD FOR IMPROVEMENT OF EFFICIENCY OF TRANSFORMATION IN PLANT, COMPRISING CO-CULTURE STEP FOR CULTURING PLANT TISSUE IN CO-CULTURE MEDIUM CONTAINING 3,6-DICHLORO-o-ANISIC ACID |
| 12/23/2009 | EP2135069A1 Serial siphon valves for fluidic or microfluidic devices |
| 12/23/2009 | EP2134847A2 Pig model for atherosclerosis |
| 12/23/2009 | EP2134845A2 Polynucleotides for regulation of high level tissue-preferred expression in crop plants |
| 12/23/2009 | EP2134844A2 Plants with altered root architecture, involving the rum1 gene, related constructs and methods |
| 12/23/2009 | EP2134843A1 Kunitz-type recombinant inhibitor |
| 12/23/2009 | EP2134841A2 Methods for producing active scfv antibodies and libraries therefor |
| 12/23/2009 | EP2134840A1 Method for purifying biomolecules |
| 12/23/2009 | EP2134839A1 Herbicide-resistant sunflower plants with multiple herbicide resistant alleles of ahasl1 and methods of use |
| 12/23/2009 | EP2134837A1 Delta 9 elongases and their use in making polyunsaturated fatty acids |
| 12/23/2009 | EP2134375A2 piRNA AND USES RELATED THERETO |
| 12/23/2009 | EP2134374A2 Sirna-mediated silencing of genes for treating chemotherapeutic drug-resistant epithelial tumours |
| 12/23/2009 | EP2134363A2 Compositions and methods for treatment of cervical cancer |
| 12/23/2009 | EP2134359A2 Use of an avirulent bordetella mutant as a live vaccine vector |
| 12/23/2009 | EP2134178A1 Method for better utilising the production potential of transgenic plants |
| 12/23/2009 | EP2134173A2 Treatment of diseases characterized by inflammation |
| 12/23/2009 | EP2134159A2 Ahas mutants |
| 12/23/2009 | EP1687329B1 Optimized expression of hpv 58 l1 in yeast |
| 12/23/2009 | EP1490496B1 Early inflorescence-preferred regulatory elements and uses thereof |
| 12/23/2009 | EP1483297B1 Antibodies derived from anti ed-b l19 and targeting tumor vasculature |
| 12/23/2009 | EP1453484B1 Methods and materials for detecting genetic material |
| 12/23/2009 | EP1421174B1 Hematopoietic cell e-selectin/l-selectin ligand polypeptides and methods of use thereof |
| 12/23/2009 | EP1397499B1 Aav helper plasmids for helper virus-free packaging and pseudo typification of aav vectors |
| 12/23/2009 | EP1385946B1 A system for inducible expression in eukaryotic cells |
| 12/23/2009 | EP1383874B1 Variants of lipoxygenase and their use |
| 12/23/2009 | EP1341808B1 Synthetic nucleic acid molecule compositions and methods of preparation |
| 12/23/2009 | EP1312259B1 Type iii allergic inflammation model animal |
| 12/23/2009 | EP1290028B1 A GENE ENCODING A MULTIDRUG RESISTANCE HUMAN P-GLYCOPROTEIN HOMOLOGUE ON CHROMOSOME 7p15-21 AND USES THEREOF |
| 12/23/2009 | EP1274861B1 Compositions and methods for identifying and targeting cancer cells |
| 12/23/2009 | EP1274726B1 Therapeutic compounds and methods for modulating v3, a versican isoform |
| 12/23/2009 | EP1104471B1 Pesticidal toxins and genes from bacillus laterosporus strains |
| 12/23/2009 | EP1094837B1 Porcine circovirus and parvovirus vaccine |
| 12/23/2009 | EP0942989B1 Method for the production of 1,3-propanediol by recombinant organisms |